Complementarity of phosphorylated histones H2AX and H3 quantification in different cell lines for genotoxicity screening
- 671 Downloads
The in vitro micronucleus assay is broadly used, but is not per se able to discriminate aneugenic from clastogenic compounds, and cytotoxicity can be a confounding factor. In vitro genotoxicity assays generally rely on cell lines with limited metabolic capabilities. Recently, the use of histone H2AX and H3 phosphorylation markers (γH2AX and p-H3) was proposed to discriminate aneugenic from clastogenic chemicals. The aim of the present study was to develop a new genotoxic screening strategy based on the use of the γH2AX and p-H3 biomarkers in combination with cell lines with distinct biotransformation properties. First, we tested a training set of 20 model chemicals comprised of 10 aneugens, five clastogens and five cytotoxics on three human cell lines (HepG2, LS-174T and ACHN). Our data confirm the robustness of these two biomarkers to discriminate efficiently clastogens, aneugens and misleading cytotoxic chemicals in HepG2 cells. Aneugenic compounds induced either an increase or a decrease in p-H3 depending on their mode of action. Clastogens induced γH2AX, and cytotoxic compounds generated a marked decrease in these two biomarkers. Moreover, the use of different cell lines permits to discriminate direct from bioactivated genotoxins without the need of an exogenous metabolic activation system. Finally, we further evaluated this strategy using a test set of 13 chemicals with controversial genotoxic potential. The resulting data demonstrate that the combined analysis of γH2AX and p-H3 is an efficient strategy. Notably, we demonstrated that three compounds (fisetin, hydroquinone and okadaic acid) display both aneugenic and clastogenic properties.
KeywordsGenotoxicity H2AX H3 HepG2 Metabolism
This work benefited from fruitful discussions with many genotoxicity experts who generously shared their experience, special thanks to Drs. David Kirkland, Richard Walmsley, Steven Bryce and Stephen Dertinger.
This work was supported in part by the French ANSES MYCO-TOX EST-13-214 and ANR “Contreperf” Grants.
- Bryce SM, Bemis JC, Mereness JA, Spellman RA, Moss J, Dickinson D, Schuler MJ, Dertinger SD (2014) Interpreting in vitro micronucleus positive results: simple biomarker matrix discriminates clastogens, aneugens, and misleading positive agents. Environ Mol Mutagen 55:542–555CrossRefPubMedGoogle Scholar
- EFSA (2007) Conclusion regarding the peer review of the pesticide risk assessment of the active substance fludioxonil. http://www.efsa.europa.eu/en/efsajournal/doc/praper_concl_sr110_fludioxonil_en.pdf?ssbinary=true
- Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T, Graham JA, Demur C, Hercend T, Diu-Hercend A, Su M, Golec JM, Miller KM (2004) VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 10:262–267CrossRefPubMedGoogle Scholar
- Khoury L, Zalko D, Audebert M (2015) Evaluation of four human cell lines with distinct biotransformation properties for genotoxic screening. Mutagenesis. doi: 10.1093/mutage/gev058
- Kligerman AD, Young RR, Stankowski LF, Jr, Pant K, Lawlor T, Aardema MJ, Houck KA (2015) An evaluation of 25 selected ToxCast chemicals in medium-throughput assays to detect genotoxicity. Environ Mol Mutagen 2014 Dec 23. doi: 10.1002/em.21934
- Lin J, Schyschka L, Muhl-Benninghaus R, Neumann J, Hao L, Nussler N, Dooley S, Liu L, Stockle U, Nussler AK, Ehnert S (2012) Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism. Arch Toxicol 86:87–95CrossRefPubMedGoogle Scholar
- Vinken M, Doktorova T, Ellinger-Ziegelbauer H, Ahr HJ, Lock E, Carmichael P, Roggen E, van Delft J, Kleinjans J, Castell J, Bort R, Donato T, Ryan M, Corvi R, Keun H, Ebbels T, Athersuch T, Sansone SA, Rocca-Serra P, Stierum R, Jennings P, Pfaller W, Gmuender H, Vanhaecke T, Rogiers V (2008) The carcinoGENOMICS project: critical selection of model compounds for the development of omics-based in vitro carcinogenicity screening assays. Mutat Res 659:202–210CrossRefPubMedGoogle Scholar
- Williams GM, Brunnemann KD, Smart DJ, Molina D, Jeffrey AM, Duan JD, Krebsfaenger N, Kampkoetter A, Schmuck G (2013) Relationship of cellular topoisomerase IIalpha inhibition to cytotoxicity and published genotoxicity of fluoroquinolone antibiotics in V79 cells. Chem Biol Interact 203:386–390CrossRefPubMedGoogle Scholar